Keyword Connections

antiviral agents / pharmacology*

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

23

1 In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

2 Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus

3 Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats

4 Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes

5 Antiviral properties of extract of Opuntia streptacantha

6 Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

7 In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses

8 Inhibitory effect of pyridobenzazoles on virus replication in vitro

9 Synthesis and antiviral activity of benzyl-substituted imidazo [1,5-a]-1,3,5-triazine (5,8-diaza-7,9-dideazapurine) derivatives

10 Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides

11 Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats

12 Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity

13 Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

14 Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants

15 Dextrans produced by lactic acid bacteria exhibit antiviral and immunomodulatory activity against salmonid viruses

16 Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

17 Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China

18 Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

19 In vitro and in vivo activities of anti-influenza virus compound T-705

20 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

21 Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods

22 Mechanism of action of T-705 against influenza virus

23 Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance